Hemanext

Lexington, MA · Founded 2000 · Privately Held (backing)

Developer of transfusion medical technology designed to support the transfusion medicine community in efforts to save lives and improve patient outcomes. Hemanext is based in Lexington, MA and was founded in 2000. Its last reported valuation was $115 million in Oct 2024. It has raised $220 million across 6 recorded rounds; the latest was a $20 million early-stage round in Jul 2025.

Last reported valuation
$115.0M
Oct 2026
Priced at
—
Total raised
$220.3M
Last round
Early Stage VC
Jul 2025
What is Hemanext worth?
$115.0Mlast reported valuation · Oct 2026

Hemanext's last reported valuation, Oct 2024. Nothing priced has surfaced since.

Free account
More of Hemanext with a free account
  • ·The complete investor list: 12 names
  • ·Watch Hemanext: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Hemanext funding history

6 rounds
DateRoundRaisedPost-money
Jul 2025Early Stage VC$20.0M▮
Nov 2024Early Stage VC$21.7M▮
Dec 2023Early Stage VC$5.0M▮
Jun 2023Early Stage VC$11.3M▮
Jul 2022Early Stage VC$13.2M▮
Aug 2019Early Stage VC$39.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Hemanext valuation

Hemanext's last reported valuation was $115 million in Oct 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Hemanext raised?

Hemanext has raised $220 million across 6 recorded rounds since 2019. The largest was a $5 million early-stage round in Dec 2023; the most recent was a $20 million early-stage round in Jul 2025.

Hemanext has filed 7 Form Ds with the SEC since 2020, most recently in Aug 2025 ($20 million sold to 29 investors).

How Hemanext's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Hemanext, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Hemanext

What is Hemanext worth?
Hemanext is valued at $115.0M as of Oct 2026. Hemanext's last reported valuation, Oct 2024. Nothing priced has surfaced since.
How much has Hemanext raised?
Hemanext has raised $220.3M in total funding across 6 recorded rounds.
When did Hemanext last raise?
Hemanext last raised in Jul 2025 (Early Stage VC), raising $20.0M.